Post Profile

Government Considers Overdose Antidote, Naloxone, to Fight Prescription Drug Misuse

3 years agoHealth : Healthland

The U.S. Food and Drug Administration (FDA) has for the first time advocated considering the distribution of the naloxone, an overdose antidote, as a way to curb the rising toll of overdose deaths in America. The federal agency stated its position at a press briefing on Wednesday held jointly with the drug czar’s office, the [...]
read more


Related Posts

FDA panel considers appeal of agency’s decision to revoke approval of Avastin for breast cancer treatment

Health : The Checkup (4 years ago)

A key federal panel opened an unusual two-day hearing Tuesday on whether to revoke government authorization of the blockbuster drug Avastin to treat advanced breast cancer. The six-member Food and Drug Administration advisory commit...

DrugScope: NTA Naloxone Pilot Scheme Can Help Reduce Drug-related Deaths, UK

Health : Medical News Today (6 years ago)

DrugScope has today welcomed the National Treatment Agency's announcement of a pilot scheme that will see families and carers of opiate users trained in drug overdose management and the administration of naloxone, a drug which rever...

Preventing Overdose: Obama Administration Drug Czar Calls For Wider Access to Overdose Antidote

Health : Healthland (3 years ago)

Speaking on Wednesday at a North Carolina overdose-prevention program, the Obama administration’s drug czar Gil Kerlikowske called for increased action to prevent drug overdose deaths. Notably, Kerlikowske urged wider distribution o...

FDA Holds Hearing to Consider Over-the-Counter Naloxone Sales

News : Reason (3 years ago)

Naloxone, a very little-known but amazing drug (which we've written about here at Reason in the past) that can save the lives of opiate overdose sufferers, might get made street-legal by the Food and Drug Administration, a no-braine...

Naloxone Debate: FDA Hears Testimony About Making an Overdose Antidote Nonprescription

Health : Healthland (3 years ago)

“Why didn’t I know about this when my child was alive?” That was the question raised over and over at a U.S. Food and Drug Administration (FDA) hearing on Thursday by parents whose families make up the terrible statistics on opioid ...


Copyright © 2015 Regator, LLC